Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study

BACKGROUND: Triplet chemotherapy, with docetaxel-5FU-oxaliplatin (TEFOX), has yielded promising results in patients with advanced and operable gastric adenocarcinoma. This may prove useful in treating signet ring cell carcinoma (SRCC), which is known to be chemoresistant and has a poor prognosis. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Pernot, Simon, Dubreuil, Olivier, Aparicio, Thomas, Le Malicot, Karine, Tougeron, David, Lepère, Céline, Lecaille, Cedric, Marthey, Lysiane, Palle, Juliette, Bachet, Jean-Baptiste, Zaanan, Aziz, Taieb, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133962/
https://www.ncbi.nlm.nih.gov/pubmed/29872148
http://dx.doi.org/10.1038/s41416-018-0133-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133962/
https://www.ncbi.nlm.nih.gov/pubmed/29872148
http://dx.doi.org/10.1038/s41416-018-0133-7

Ejemplares similares